Healthy volunteers help test two pill strengths for future cancer drug
NCT ID NCT05391048
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 25 times
Summary
This study tested whether a 10 mg and a 20 mg capsule of an experimental drug called IMP4297 are processed the same way in the body. It involved 36 healthy Chinese adults who took a single dose of each strength on separate days. The goal was to gather information on how the drug behaves, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, 221000, China
Conditions
Explore the condition pages connected to this study.